New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export SNY’s income statement to Excel — free account
Sanofi
SNYHealthcare Drug Manufacturers General
Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.
- Revenue
- +13.9%
- EPS
- +8.21%
- Free cash flow
- +99.6%
- Total debt
- −11.2%
Quarter to September 2026, against a year earlier
46.59
0.53
+1.15%
Follow SNY
Alert me
Revenue to profit Fiscal 2025, year to Dec 31, 2025
Of every $100 of revenue, $10.57 was left as profit. Gross margin has risen two years running, from 69.3% to 72.1%. What is an income statement?
| Revenue | 52.9 | 100.0% |
|---|---|---|
| Cost of revenue | −14.8 | −27.9% |
| Gross profit | 38.1 | 72.1% |
| Research & development | −8.9 | −16.8% |
| Selling, general & admin | −10.8 | −20.4% |
| Other operating costs | −8.6 | −16.3% |
| Operating income | 9.8 | 18.6% |
| Other income, net | −2.8 | −5.4% |
| Income tax | −1.2 | −2.2% |
| Other items | −0.2 | −0.4% |
| Net income | 5.6 | 10.6% |
Net margin (right axis)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.4B | $40.9B | $42.1B | $42.1B | $42.7B | $46.3B | $47.8B | $50.3B | $47.9B | $52.9B |
| Operating income | $7.6B | $7.1B | $6.2B | $7.3B | $16.4B | $9.8B | $10.7B | $9.6B | $8.2B | $9.8B |
| Net income | $5.2B | $9.5B | $5.1B | $3.1B | $14.1B | $7.4B | $8.8B | $5.8B | $5.9B | $5.6B |
| Net margin (right axis) | 13.6% | 23.3% | 12.1% | 7.5% | 33.0% | 15.9% | 18.4% | 11.6% | 12.4% | 10.6% |
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
52,854.48 | 47,921.88 | 50,266.34 | 47,821.85 | 46,347.94 | 42,686.61 | 42,146.72 | 42,134.54 | 40,921.38 | 38,407.87 |
Revenue Growth |
10.29% | (4.66%) | 5.11% | 3.18% | 8.58% | 1.28% | 0.03% | 2.96% | 6.54% | (0.78%) |
Cost of Revenue |
14,763.64 | 14,289.13 | 15,407.62 | 14,429.05 | 14,498.89 | 13,886.94 | 13,413.12 | 13,504.74 | 13,123.91 | 11,842.83 |
Gross Profit |
38,090.84 | 33,632.75 | 34,858.72 | 33,392.80 | 31,849.05 | 28,799.67 | 28,733.60 | 28,629.80 | 27,797.47 | 26,565.04 |
R&D Expenses |
8,872.44 | 8,001.05 | 7,281.71 | 7,065.44 | 6,734.21 | 6,315.78 | 6,740.16 | 6,960.81 | 6,185.00 | 5,723.34 |
SG&A Expenses |
10,796.95 | 9,936.92 | 11,571.95 | 11,054.37 | 11,304.52 | 10,726.20 | 11,068.96 | 11,643.48 | 11,368.56 | 10,497.21 |
Operating Income |
9,830.73 | 8,219.63 | 9,593.50 | 10,720.38 | 9,845.76 | 16,388.58 | 7,269.91 | 6,232.14 | 7,070.03 | 7,592.38 |
Non-operating Income/Expense |
(2,844.34) | (971.73) | (1,851.81) | 260.24 | (619.94) | (620.27) | (4,109.28) | (1,029.83) | (819.47) | (1,309.11) |
Non-operating Interest Expenses |
636.98 | 1,161.09 | 1,421.06 | 463.58 | 435.38 | 445.50 | 497.28 | 513.74 | 474.73 | 1,022.50 |
| 6,986.40 | 7,247.91 | 7,741.69 | 10,980.62 | 9,225.81 | 15,768.31 | 3,160.64 | 5,202.31 | 6,250.56 | 6,283.28 | |
Income Tax Provision |
1,180.05 | 1,302.85 | 1,733.85 | 2,113.52 | 1,843.27 | 2,070.99 | 155.68 | 568.06 | 1,946.38 | 1,467.35 |
Income after Tax |
5,806.35 | 5,945.06 | 6,007.85 | 8,867.10 | 7,382.54 | 13,697.32 | 3,004.96 | 4,634.24 | 4,304.18 | 4,815.92 |
Share of Subsidiary Earnings |
(175.37) | 64.93 | (124.46) | 71.64 | 46.14 | 410.09 | 285.60 | 589.32 | 117.55 | 148.28 |
Dividends (Preferred) |
— | — | — | 0.00 | 0.00 | — | 113.12 | 15.35 | (5,247.98) | (347.47) |
Non-Controlling Interest |
42.99 | 62.76 | 38.96 | 119.06 | 66.25 | 41.12 | 34.72 | 122.82 | 136.77 | 100.70 |
Net Income Common |
8,839.63 | 6,016.48 | 5,844.42 | 8,819.69 | 7,362.43 | 14,066.28 | 3,142.72 | 5,085.39 | 9,532.95 | 5,210.98 |
EPS (Basic) |
3.62 | 2.48 | 2.33 | 3.52 | 2.94 | 5.61 | 1.24 | 2.04 | 1.76 | 2.03 |
EPS (Diluted) |
3.62 | 2.48 | 2.33 | 3.51 | 2.94 | 5.61 | 1.24 | 2.04 | 1.75 | 2.03 |
Shares (Basic, Weighted) |
2,440.80 | 2,502.80 | 2,503.40 | 2,503.80 | 2,505.00 | 2,507.20 | 2,499.80 | 2,494.20 | 2,513.80 | 2,573.20 |
Shares (Diluted, Weighted) |
2,451.20 | 2,512.20 | 2,512.80 | 2,513.80 | 2,515.80 | 2,520.20 | 2,514.20 | 2,510.40 | 2,533.60 | 2,592.00 |
Gross Margin |
72.07% | 70.18% | 69.35% | 69.83% | 68.72% | 67.47% | 68.18% | 67.95% | 67.93% | 69.17% |
EBIT Margin |
18.60% | 17.15% | 19.09% | 22.42% | 21.24% | 38.39% | 17.25% | 14.79% | 17.28% | 19.77% |
EBT margin |
13.22% | 15.12% | 15.40% | 22.96% | 19.91% | 36.94% | 7.50% | 12.35% | 15.27% | 16.36% |
Net Profit Margin |
16.72% | 12.55% | 11.63% | 18.44% | 15.89% | 32.95% | 7.46% | 12.07% | 23.30% | 13.57% |
Free Cash Flow Margin |
17.25% | 16.59% | 17.76% | 21.62% | 23.48% | 16.73% | 19.01% | 16.07% | 16.46% | 17.18% |
EBITDA |
16,254.82 | 12,100.04 | 14,779.89 | 14,323.69 | 13,810.33 | 20,596.81 | 15,616.15 | 11,285.64 | 11,236.31 | 11,245.27 |
EBIT |
9,830.73 | 8,219.63 | 9,593.50 | 10,720.38 | 9,845.76 | 16,388.58 | 7,269.91 | 6,232.14 | 7,070.03 | 7,592.38 |
Income from Continuous Operations |
5,630.98 | 6,009.98 | 5,883.38 | 8,938.74 | 7,428.69 | 14,107.41 | 3,290.56 | 5,223.56 | 4,421.73 | 4,964.21 |
Income from Discontinued Operations |
3,251.64 | 69.25 | — | — | — | — | — | — | — | — |
Consolidated Net Income/Loss |
8,882.62 | 6,079.24 | 5,883.38 | 8,938.74 | 7,428.69 | 14,107.41 | 3,290.56 | 5,223.56 | 4,421.73 | 4,964.21 |
EPS (Basic, from Continuous Ops) |
2.31 | 2.40 | 2.35 | 3.57 | 2.97 | 5.63 | 1.32 | 2.09 | 1.76 | 1.93 |
EPS (Basic, from Discontinued Ops) |
1.33 | 0.03 | — | — | — | — | — | — | — | — |
EPS (Basic, Consolidated) |
3.64 | 2.43 | 2.35 | 3.57 | 2.97 | 5.63 | 1.32 | 2.09 | 1.76 | 1.93 |
EPS (Diluted, from Cont. Ops) |
2.30 | 2.39 | 2.34 | 3.56 | 2.95 | 5.60 | 1.31 | 2.08 | 1.75 | 1.92 |
EPS (Diluted, from Disc. Ops) |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Shares (Diluted, Average) |
2,440.80 | 2,502.80 | 2,503.40 | 2,503.80 | 2,505.00 | 2,507.20 | 2,505.36 | 2,494.00 | 2,513.80 | 2,573.20 |
EPS (Diluted, Consolidated) |
3.62 | 2.42 | 2.34 | 3.56 | 2.95 | 5.60 | 1.31 | 2.08 | 1.75 | 1.92 |
EBITDA Margin |
30.75% | 25.25% | 29.40% | 29.95% | 29.80% | 48.25% | 37.05% | 26.78% | 27.46% | 29.28% |
Operating Cash Flow Margin |
23.01% | 20.51% | 22.09% | 23.19% | 26.86% | 19.93% | 20.58% | 15.55% | 20.38% | 22.58% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 5, 2026